12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

NuPathe sales and marketing update

NuPathe said it will not launch Zecuity sumatriptan for migraines this quarter as previously expected. The company said commercialization...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >